Ontology highlight
ABSTRACT: Aim
To describe population-level time trends in prescribing patterns of type 2 diabetes therapy, and in short-term clinical outcomes (glycated haemoglobin [HbA1c], weight, blood pressure, hypoglycaemia and treatment discontinuation) after initiating new therapy.Materials and methods
We studied 81 532 people with type 2 diabetes initiating a first- to fourth-line drug in primary care between 2010 and 2017 inclusive in United Kingdom electronic health records (Clinical Practice Research Datalink). Trends in new prescriptions and subsequent 6- and 12-month adjusted changes in glycaemic response (reduction in HbA1c), weight, blood pressure and rates of hypoglycaemia and treatment discontinuation were examined.Results
Use of dipeptidyl peptidase-4 inhibitors as second-li
SUBMITTER: Dennis JM
PROVIDER: S-EPMC6618851 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature